HCA Healthcare, Inc. provided earning guidance for 2024. For the period, the company expects revenues in the range of $67.75 to $70.25 billion, Net Income Attributable to HCA Healthcare, Inc. in the range of $5.20 to $5.60 billion and EPS (diluted) in the range of $19.70 to $21.20 per diluted share.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
328.4 USD | +2.96% | +3.68% | +20.78% |
07-12 | Bernstein Adjusts Price Target on HCA Healthcare to $362 From $317 | MT |
07-09 | Barclays Adjusts HCA Healthcare's Price Target to $376 From $367, Keeps Overweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.78% | 83.53B | |
-22.21% | 75.4B | |
+2.32% | 26.73B | |
-3.88% | 18.25B | |
+7.37% | 18.12B | |
+8.68% | 16.51B | |
+77.78% | 14.05B | |
+78.46% | 13.03B | |
-27.89% | 12.67B | |
+22.96% | 12.31B |
- Stock Market
- Equities
- HCA Stock
- News HCA Healthcare, Inc.
- HCA Healthcare, Inc. Provides Earning Guidance for 2024